A new ligand extends the half-life of peptide drugs from minutes to days -- COMPAMED Trade Fair

A new ligand extends the half-life of peptide drugs from minutes to days

07/20/2017

Image: A bicyclic peptide (white) bound to serum albumin (red) through the newly developed ligand (green), floating in the bloodstream; Copyright: C. Heinis/EPFL

The lab of Christian Heinis at EPFL has now developed such a ligand, which has a high affinity for human albumin and - more importantly - is easy to synthesize and attach to a peptide; © C. Heinis/EPFL